A case of dramatic response to pembrolizumab monotherapy in dMMR unresectable colorectal cancer diagnosed following abdominal hemorrhage due to segmental arterial mediolysis

Takashi Matsumoto; Kohei Yamashita; Shinsei Yumoto; Takashi Ofuchi; Rin Yamada; Shinichiro Uemura; Masaaki Iwatsuki; Norihisa Hanada; Yoshihiro Komohara

doi:10.1007/s12328-025-02262-4

Affiliated Institutions

Related Publications

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Aurélien Marabelle , Dung T. Le , Paolo A. Ascierto +19 more

PURPOSE Genomes of tumors that are deficient in DNA mismatch repair (dMMR) have high microsatellite instability (MSI-H) and harbor hundreds to thousands of somatic mutations tha...

2019 Journal of Clinical Oncology 2734 citations

Immunotherapy in colorectal cancer: rationale, challenges and potential

Karuna Ganesh , Zsofia K. Stadler , Andrea Cercek +4 more

Following initial successes in melanoma treatment, immunotherapy has rapidly become established as a major treatment modality for multiple types of solid cancers, including a su...

2019 Nature Reviews Gastroenterology & Hep... 1861 citations

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

Michael A. Morse , Eric Van Cutsem , Ray McDermott +17 more

Purpose Nivolumab provides clinical benefit (objective response rate [ORR], 31%; 95% CI, 20.8 to 42.9; disease control rate, 69%; 12-month overall survival [OS], 73%) in previou...

2018 Journal of Clinical Oncology 1962 citations

Nivolumab in patients with DNA mismatch repair deficient/microsatellite instability high metastatic colorectal cancer: Update from CheckMate 142.

Michael J. Overman , Sara Lonardi , Francesco Leone +16 more

519 Background: Approximately 4% of metastatic colorectal cancers (mCRCs) are associated with high microsatellite instability (MSI-H), indicating a deficient DNA mismatch repair...

2017 Journal of Clinical Oncology 69 citations

Deficient mismatch repair system in patients with sporadic advanced colorectal cancer

Miriam Koopman , Guus A. M. Kortman , Leonie J. Mekenkamp +5 more

A deficient mismatch repair system (dMMR) is present in 10-20% of patients with sporadic colorectal cancer (CRC) and is associated with a favourable prognosis in early stage dis...

2009 British Journal of Cancer 501 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

A case of dramatic response to pembrolizumab monotherapy in dMMR unresectable colorectal cancer diagnosed following abdominal hemorrhage due to segmental arterial mediolysis

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Takashi Matsumoto, 
                                
                                    Kohei Yamashita, 
                                
                                    Shinsei Yumoto
                                
                                et al.
                            
                            (2025). 
                            A case of dramatic response to pembrolizumab monotherapy in dMMR unresectable colorectal cancer diagnosed following abdominal hemorrhage due to segmental arterial mediolysis. 
                            Clinical Journal of Gastroenterology
                            
                            .
                            https://doi.org/10.1007/s12328-025-02262-4

Identifiers

DOI: 10.1007/s12328-025-02262-4